Clinical Trial

Asia Myelodysplastic Syndrome (MDS) Registry

Name: Asia Myelodysplastic Syndrome (MDS) Registry — clinical trial record (NCT07355478)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to provide a contemporary view and offer invaluable insights into the demographic profiles, clinical characteristics, treatments, and real-world outcomes of individuals with myelodysplastic syndromes (MDS) in Asia.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-14.

Trial Details

NCT Number	NCT07355478
Lead Sponsor	Bristol-Myers Squibb
Conditions	Myelodysplastic Syndromes (MDS)
Enrollment	500 participants
Start Date	2026-03-26
Primary Completion	2026-10-31 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-13